International journal of clinical practice
-
Int. J. Clin. Pract. · Jun 2010
Randomized Controlled Trial Multicenter StudyEfficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the START study.
The benefits of taking almotriptan early for acute migraine when pain is mild have clearly been demonstrated in the neurology setting. The aim of this study was to determine whether similar benefits with early intervention of almotriptan can be achieved in everyday general practice, where most migraineurs are managed. ⋯ In the primary care setting, early intervention with almotriptan for treatment of migraine provides significant clinical benefits compared with delaying treatment and/or waiting until pain intensity has progressed beyond mild.